• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠胰神经内分泌肿瘤的循环生物标志物:在诊断、疾病监测及预后指标中的应用。

Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.

机构信息

Regional Regulatory Peptide Laboratory, Kelvin Building, Royal Victoria Hospital, Grosvenor Road, Belfast, BT 126BA, UK.

出版信息

Endocrinol Metab Clin North Am. 2010 Dec;39(4):777-90. doi: 10.1016/j.ecl.2010.09.001.

DOI:10.1016/j.ecl.2010.09.001
PMID:21095544
Abstract

Neuroendocrine tumors (NETs) are difficult to diagnose. Their symptoms may be vague or intermittent, and are frequently associated with much more common diseases; many of the tumors may be asymptomatic. Therefore, diagnosis can be delayed for some years. Because most NETs are secretory, the measurement of circulating biomarkers is helpful not only for diagnosis but also for assessing tumor response to treatment, monitoring disease progression, and use as prognostic indicators.

摘要

神经内分泌肿瘤(NET)很难诊断。其症状可能较为模糊或间歇性,且常与更为常见的疾病相关联;许多肿瘤可能无症状。因此,诊断可能会延迟数年。由于大多数 NET 是分泌性的,因此循环生物标志物的测量不仅有助于诊断,还有助于评估肿瘤对治疗的反应、监测疾病进展以及用作预后指标。

相似文献

1
Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.肠胰神经内分泌肿瘤的循环生物标志物:在诊断、疾病监测及预后指标中的应用。
Endocrinol Metab Clin North Am. 2010 Dec;39(4):777-90. doi: 10.1016/j.ecl.2010.09.001.
2
Angiopoietin-2 promotes disease progression of neuroendocrine tumors.血管生成素-2 促进神经内分泌肿瘤的疾病进展。
Clin Cancer Res. 2010 Jan 15;16(2):420-9. doi: 10.1158/1078-0432.CCR-09-1924. Epub 2010 Jan 12.
3
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.嗜铬粒蛋白 A 作为胃肠胰神经内分泌肿瘤生物标志物的临床相关性。
Endocrinol Metab Clin North Am. 2011 Mar;40(1):111-34, viii. doi: 10.1016/j.ecl.2010.12.001.
4
Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.嗜铬粒蛋白 A:一种用于检测和治疗后监测胃肠胰神经内分泌肿瘤的敏感生物标志物。
Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):313-34. doi: 10.1586/egh.12.15.
5
Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤的预后和预测生物标志物
JOP. 2013 Mar 10;14(2):155-7. doi: 10.6092/1590-8577/1472.
6
Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤中的循环生物标志物
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S17-25. doi: 10.1530/ERC-10-0280. Print 2011 Oct.
7
Preface: Gastroenteropancreatic system and its tumors: Part 1.前言:胃肠胰系统及其肿瘤:第1部分。
Endocrinol Metab Clin North Am. 2010 Dec;39(4):xvii-xviii. doi: 10.1016/j.ecl.2010.09.005. Epub 2010 Sep 29.
8
Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis.神经内分泌肿瘤患者循环血管生成素-2水平升高,且与疾病负担和预后相关。
Endocr Relat Cancer. 2009 Sep;16(3):967-76. doi: 10.1677/ERC-09-0089. Epub 2009 Jun 5.
9
Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.胃肠道和胰胆管神经内分泌肿瘤的最新进展
Arch Pathol Lab Med. 2016 May;140(5):437-48. doi: 10.5858/arpa.2015-0314-RA.
10
Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.血浆嗜铬粒蛋白 A 对奥曲肽试验的反应:对内分泌消化系统肿瘤临床转归的预后价值。
Am J Gastroenterol. 2010 Sep;105(9):2072-8. doi: 10.1038/ajg.2010.154. Epub 2010 Apr 6.

引用本文的文献

1
A Rare Case of Neuroendocrine Tumor Presenting as Isolated Scalp Swelling With Paroxysmal Symptoms.一例罕见的以孤立性头皮肿胀伴阵发性症状为表现的神经内分泌肿瘤
Cureus. 2025 Jul 17;17(7):e88202. doi: 10.7759/cureus.88202. eCollection 2025 Jul.
2
[Search for new immunohistochemical and circulating markers of insulinoma].[寻找胰岛素瘤新的免疫组化及循环标志物]
Probl Endokrinol (Mosk). 2024 May 13;70(6):15-26. doi: 10.14341/probl13466.
3
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development-A Comprehensive Review.
神经内分泌肿瘤的生化标志物:传统循环标志物与最新进展——综述
Diagnostics (Basel). 2024 Jun 18;14(12):1289. doi: 10.3390/diagnostics14121289.
4
Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance-A Retrospective, Long-Term Single-Center Experience.未知原发灶神经内分泌肿瘤(NEN-UPs)的诊断方法及其预后相关性——一项回顾性、长期单中心经验
Cancers (Basel). 2023 Aug 29;15(17):4316. doi: 10.3390/cancers15174316.
5
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors.嗜铬粒蛋白A检测在神经内分泌肿瘤检查中的诊断效用有限。
Diagnostics (Basel). 2020 Oct 29;10(11):881. doi: 10.3390/diagnostics10110881.
6
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.血嗜铬粒蛋白 A 作为支气管肺神经内分泌肿瘤/肿瘤的诊断或治疗标志物并不有效。
Neuroendocrinology. 2020;110(3-4):185-197. doi: 10.1159/000500202. Epub 2019 Apr 16.
7
Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?激素分泌型胃-肠-胰神经内分泌肿瘤(GEP-NEN):何时考虑,如何诊断?
Rev Endocr Metab Disord. 2017 Dec;18(4):393-410. doi: 10.1007/s11154-017-9438-8.
8
Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls.嗜铬粒蛋白A——非特异性神经内分泌标志物。临床应用及潜在诊断陷阱。
Arch Med Sci. 2016 Feb 1;12(1):1-9. doi: 10.5114/aoms.2016.57577. Epub 2016 Feb 2.
9
Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.意大利临床内分泌学家协会(AME)立场声明:胃肠胰神经内分泌肿瘤诊断的逐步临床方法
J Endocrinol Invest. 2014 Sep;37(9):875-909. doi: 10.1007/s40618-014-0119-0. Epub 2014 Jul 20.
10
Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib.胰腺神经内分泌肿瘤:以舒尼替尼为重点的治疗方法。
Therap Adv Gastroenterol. 2013 Sep;6(5):396-411. doi: 10.1177/1756283X13493878.